INVEST IN An allergy-free Futre.

1. 30% of households can’t have pets due to allergies. Source.

2. Currently, there is no such thing as a truly hypoallergenic dog. Although some individual dogs may indeed elicit fewer allergy symptoms than others, studies suggest that there is no specific breed that is truly hypoallergenic. Source.

3. Each person who qualifies for a "Company Perk" will be assigned a spot in line in their respective tier. Once the allotment for each tier is exhausted, there will be no more company perk for that tier this round. The company perks are transferrable and apply to the first animals that are commercialized to the public. Not applicable to those sold to breeders as breeding stock, those provided free of charge, or those used for clinical studies. The perk is not for the animal itself but for the spot in line. Investors who satisfy the criteria for each tier are still required to pay for their AdoraPet animal.

4. 95% of pet owners consider their pets part of their family. Source.

5. Over 6 million cats and dogs enter shelters every year. Source.

6. 11% of cats are surrendered because their owners have allergies. Source.

7. U.S. pet sales have grown 100% in the last decade. Source.

‍

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.

‍

DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 105 Maxess Road, Suite 124, Melville, NY  11747, is the Intermediary for this offering and is not an affiliate of or connected with the Issuer.  Please check our background on FINRA's BrokerCheck.

‍

DealMaker Securities LLC does not make investment recommendations.

‍

DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer.

‍

DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment.

‍

DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing.

‍

DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself.

‍

Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically.   DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.